Please note that login will be disabled for maintenance during the period: 13:00 - 14:00 GMT

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

4th EUTROC

2 - 3 Nov 2012

Working as a gynaecological surgeon

Dr John Kirawan - Liverpool Women's Hospital, UK
Working as a gynaecological surgeon ( Dr John Kirawan - Liverpool Women's Hospital, UK )
13 Feb 2013

Highlights from the 4th EUTROC meeting

Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012

Histological and molecular sub types of ovarian cancer

Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands
Histological and molecular sub types of ovarian cancer ( Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands )
15 Nov 2012

Development of clinical trials and biobanks

Prof Hani Gabra – Imperial College London, UK
Development of clinical trials and biobanks  ( Prof Hani Gabra – Imperial College London, UK )
15 Nov 2012

The AKT pathway and chemotherapy resistant ovarian cancer

Dr Euan Stronach – Imperial College London, UK
The AKT pathway and chemotherapy resistant ovarian cancer ( Dr Euan Stronach – Imperial College London, UK )
15 Nov 2012

Ovarian cancer tumour banks and collaboration

Dr Elena Braicu - Charite University Hospital, Berlin, Germany
Ovarian cancer tumour banks and collaboration ( Dr Elena Braicu - Charite University Hospital, Berlin, Germany )
15 Nov 2012

Interplay between pathologies of ovarian cancer and genomics

Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012

Biology of molecular sub types in ovarian cancer

Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia
Biology of molecular sub types in ovarian cancer ( Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia )
15 Nov 2012

Sub-typing ovarian cancer

Dr Charles Gourley – University of Edinburgh Cancer Research Center, UK
Sub-typing ovarian cancer ( Dr Charles Gourley – University of Edinburgh Cancer Research Center, UK )
15 Nov 2012

Early stage biomarkers in ovarian cancer

Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy
Early stage biomarkers in ovarian cancer ( Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy )
15 Nov 2012

The Merseyside and Cheshire cancer network

Dr John Kirwan – Liverpool Womens Hospital, UK
The Merseyside and Cheshire cancer network ( Dr John Kirwan – Liverpool Womens Hospital, UK )
15 Nov 2012

Drug approval process for ovarian cancer

Prof Maria Paolo Costi – University of Modena, Italy
Drug approval process for ovarian cancer ( Prof Maria Paolo Costi – University of Modena, Italy )
15 Nov 2012

Interaction between tumour biology and surgery

Dr Christina Fotopoulou – Charite University Hospital, Berlin, Germany
Interaction between tumour biology and surgery ( Dr Christina Fotopoulou – Charite University Hospital, Berlin, Germany )
15 Nov 2012